Background: In chronic pancreatitis (CP), a debilitating, progressive and incurable disease, patients’ wellbeing is considerably impaired, but the different factors affecting quality of life (QoL), have not been identified yet. Methods: 69 patients with CP were evaluated (M/F 55/14; mean age 46.6 ± 10.05 years). Different degrees of pancreatic damage were defined using the Cambridge classification; pain intensity and frequency were assessed using pain index. QoL was measured using EORTC QLQ-C30 and the PAN26 questionnaire. Although developed for pancreatic cancer, the C30/PAN26 has been validated for chronic pancreatitis. Results: Digestive symptoms, financial difficulties, fear of future health and general pain scales showed considerable effects of CP on QoL. We observed significant negative correlation between mean QoL scores and pain index in almost all domains (p < 0.001, p < 0.05). Pain intensity affects QoL scales more often than pain frequency. BMI correlated positively with QoL in global health status, altered bowel habits, body image and satisfaction with health care domains (p < 0.01, p < 0.05). Conclusion: Pain index, BMI, Cambridge classification and disease duration are the most important factors adversely affecting QoL in CP. Measurement of QoL is essential in the disease management and improves the knowledge of psychosocial functioning of these patients.

Keywords:
Chronic pancreatitis, EORTC QLQ-C30, EORTC PAN26, Quality of life
1.
Stewart A, Greenfield S, Hays R: Functional status and well-being of patients with chronic conditions. JAMA 1989;262:907–913.
2.
Eisen GM, Locke GR, Provenzale D: Health-related quality of life: A primer for gastroenterologists. Am J Gastroenterol 1999;94:2017–2021.
3.
Guyatt GH, Feeny D, Patrick D: Measuring health-related quality of life. Ann Intern Med 1993;118:622–629.
4.
Koloski N, Hons B, Talley N, Boyce P: The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 2000;95:67–71.
5.
Johnson CD, Fitzsimmons D: Quality of life in chronic pancreatitis; in Buchler MW, Friess H, Uhl W, Malfertheiner P (eds): Chronic Pancreatitis. Novel concepts in Biology and therapy. Hoboken, Blackwell Publishing, 2002, pp 602–606.
6.
Fitzsimmons D, Johnson CD: Measurement of symptoms and quality of life in pancreatic disease; in Johnson CD, Imrie CW (eds): Basic Sciences and Clinical Management. New York, Springer, 2004, pp 441–450.
7.
Fitzimmons D, Kahl S, Butturini G, van Wyk M, Bornman P, Bassi C, Malfertheiner P, George SL, Johnson CD: Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26. Am J Gastroenterol 2005;100:918–926.
8.
Fayers P, Bottomley A: Quality of life research within the EORTC: the EORTC QLQ-C30. Eur J Cancer 2002;38(suppl 4):S125–S133.
9.
Fayers PM: Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer 2001;37:1331–1334.
10.
Michelson H, Bolund C, Brandberg Y: Multiple chronic health problems are negatively associated with health related quality of life (HRQoL) irrespective of age. Qual Life Res 2000;9:1093–1104.
11.
Sarner M, Cotton PB: Classification of pancreatitis. Gut 1984;25:756–759.
12.
Talley NJ, Haque M, Wyeth JW: Development of a new dyspepsia impact scale: The Nepean Dyspepsia Index. Aliment Pharmacol Ther 1999;13:225–235.
13.
Wehler M, Nichterlein R, Fischer B, Farnbacher M, Reulbach U, Hahn EG, Schneider T: Factors associated with health-related quality of life in chronic pancreatitis. Am J Gastroenterol 2004;99:138–146.
14.
Pezzilli R, Fantini L: Chronic pancreatitis: assessing the quality of life. JOP 2005;6:406–409.
15.
Osoba D, Rodrigues G, Myles J, Zee B, Pater J: Interpreting of significance of changes in health-related quality of life scores. J Clin Oncol 1998;16:139–144.
16.
Izbicki JR, Bloechle C, Broering DC: Extended drainage versus resection in surgery for chronic pancreatitis: a prospective randomized trial comparing the longitudinal pancreaticojejunostomy combined with local pancreatic head excision with the pylorus-preserving pancreatoduodenectomy. Ann Surg 1998;228:771–779.
17.
Pezzilli R, Morselli-Labate AM, Fantini L, Campana D, Corinaldesi R: Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires. Dig Liver Dis 2007;39:1077–1086.
18.
Dumasy V, Delhaye M, Cotton F, Deviere J: Fat malabsorption screening in chronic pancreatitis. Am J Gastroenterol 2004;99:1350–1354.
19.
Lu CL, Chen CY, Luo JC, Chang FY, Lee SD, Wu HC, Chen JD: Impaired gastric myoelectricity in patients with chronic pancreatitis: role of maldigestion. World J Gastroenterol 2005;11:372–376.
20.
Mariani A: The quality of life in chronic pancreatitis: the endoscopist’s point of view. JOP 2006 11;7:117–119.
21.
Brand B, Kahl M, Sidhu S, Nam VC, Sriram PV, Jaeckle S, Thonke F, Soehendra N: Prospective evaluation of morphology, function and quality of life after extracorporeal shockwave lithotripsy and endoscopic treatment of chronic calcific pancreatitis. Am J Gastroenterol 2000;95:3428–3430.
© 2010 S. Karger AG, Basel and IAP
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.